Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Cash flows from operating activities
Net income	$ 112,520	$ 131,815	$ 83,414
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation	8,387	8,575	10,428
Equity-based compensation expense	17,562	11,465	6,113
Inventory reserve	(1,182)	1,668	600
Amortization of deferred finance costs	1,546	2,345	1,654
Change in fair value of earnout consideration liability	(14,237)	(23,337)	(9,575)
Revaluation of warrant liability	(8,047)	(18,930)	(3,485)
Change in fair value of derivative liability	139	(266)	0
Deferred tax (benefit) expense	2,667	3,193	(857)
Changes in assets and liabilities
Accounts receivable	(3,216)	(9,347)	(19,133)
Inventories	(8,984)	(18,237)	3,792
Prepaid expenses and other assets	(1,309)	(1,228)	(1,519)
Accounts payable	(1,934)	68	4,637
Accrued expenses	1,833	23	1,665
Deposits and other assets	0	(14)	0
Other liabilities	(1,433)	4,990	46
Net cash provided by operating activities	104,312	92,783	77,780
Cash flows from investing activities
Acquisition of property and equipment	(10,944)	(9,053)	(4,746)
Net cash used in investing activities	(10,944)	(9,053)	(4,746)
Cash flows from financing activities
Business combination and PIPE financing	0	0	60,826
Proceeds from employee stock purchase plan and exercise of equity awards	1,196	82	0
Proceeds from convertible notes	0	0	127,400
Payment of line of credit	0	(15,000)	(5,000)
Proceeds from term loan	0	0	250,000
Payment of term loan	(22,810)	(16,878)	(240,000)
Payments for taxes related to net share settlement of equity awards	(3,126)	0	0
Payment of tax receivable agreement liability	(2,436)	(110)	0
Deferred finance costs related to debt modification	(256)	0	(1,860)
Distributions pursuant to the business combination	0	0	(218,300)
Distributions	(38,362)	(36,293)	(22,334)
Issuance cost related to business combination	0	(23,833)	(15,244)
Net cash used in financing activities	(65,794)	(92,032)	(64,512)
Net increase (decrease) in cash and cash equivalents	27,574	(8,302)	8,522
Cash and cash equivalents, beginning of period	13,642	21,944	13,422
Cash and cash equivalents, end of period	41,216	13,642	21,944
Supplementary disclosure of cash flow information:
Cash paid for interest expense	27,247	21,379	10,101
Cash paid for income taxes	2,760	858	0
Supplemental disclosure of non-cash financing activities:
Derivative asset - interest rate swap	5,258	8,651	0
Issuance costs payable	$ 0	$ 0	$ 23,107